Option Care Health (NASDAQ:OPCH) Price Target Cut to $34.00 by Analysts at Truist Financial

Option Care Health (NASDAQ:OPCH) had its price target cut by Truist Financial from $41.00 to $34.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock.

OPCH has been the subject of several other reports. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Barrington Research dropped their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Trading Down 6.7 %

Shares of NASDAQ OPCH opened at $22.49 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day simple moving average of $30.31 and a two-hundred day simple moving average of $29.85. The firm has a market cap of $3.83 billion, a PE ratio of 18.90, a price-to-earnings-growth ratio of 1.90 and a beta of 1.32. Option Care Health has a twelve month low of $22.46 and a twelve month high of $34.63.

Insider Activity at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of OPCH. Massachusetts Financial Services Co. MA purchased a new position in shares of Option Care Health during the second quarter worth $68,003,000. Magnetar Financial LLC boosted its position in shares of Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after buying an additional 1,377,929 shares during the period. Duquesne Family Office LLC raised its stake in shares of Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Hood River Capital Management LLC raised its stake in shares of Option Care Health by 77.2% in the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock valued at $47,894,000 after acquiring an additional 753,208 shares in the last quarter. Finally, Westfield Capital Management Co. LP raised its stake in shares of Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after acquiring an additional 688,653 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.